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Chemically Modified Starches 
as Excipients in Pharmaceutical 
Dosage Forms
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Abstract
Excipients play a great role in ensuring that pharmaceutical dosage form meets 
the required specifications of quality approved by the relevant authorities. Starches 
are the most widely used excipients in dosage form development, but their use is 
enhanced by several modification methods (such as chemical degradation, physi-
cal alteration, enzymatic modifications or crystalline-genetic transformation), all 
aimed at restructuring the starch granules, thus ensuring that the reactive polymers 
are accessible to reactants. Chemical modification of starch usually follows the path-
way of substitution, degradation or cross-linking. The most common approaches 
to chemical modification of starches for pharmaceutical use include oxidation, 
esterification and etherification, which are employed to optimize the structural and 
nutritional properties for targeted applications. The oxidant type, botanical origin 
of starch, and process conditions are all determinants of how effective the oxidation 
is. Esterification improves the hydrophobicity of starch usually via acetylation and 
phosphorylation, while etherification is a derivatization technique that involves 
the use of various alkylation agents such as dimethyl sulphate, diethyl sulphate, 
alkylene oxides (epoxides) and alkyl halides. Chemically modified starch enhances 
thermoplasticity,  solubility and flow properties. In conclusion, chemically modi-
fied starches have shown excellent potentials and are, thus, incorporated as core 
excipients in several pharmaceutical drug formulations.
Keywords: excipients, modified starches, chemical modification, formulations, 
polymers
1. Introduction
The goal of an ideal oral solid-dosage drug delivery system is to achieve a situ-
ation where the desired therapeutic effect is obtained in conformity with official 
standards. Excipients play a great role in ensuring that the dosage form meets the 
required specifications of quality by modifying the release, absorption, distribution 
and elimination profiles of the drug. This assures product efficacy, safety, patient 
compliance and acceptance. Compressed tablets still account for the most widely 
used oral solid dosage form due to their compactness, precision of doses and ease 
of administration and production. The process of tableting requires that all the 
ingredients are fairly dried, powdered (or granulated) to form uniform particle 
sizes, with good content uniformity to ensure delivery of the right dose of the active 
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pharmaceutical ingredient. Excipients form a larger bulk of the constituent of tab-
lets and the presence of the excipients ensures, amongst other goals, that acceptable 
physical and mechanical properties of tablets are achieved.
Based on their primary functions, excipients are classified into two categories as 
follows:
i. Those which principally affect the compressional characteristics of the tablets: 
diluents (fillers), binders (adhesives), lubricants, glidants, anti-adherents.
ii. Those which principally affect the bio-pharmaceutics, chemical and physical 
stability: disintegrants, flavourants, sweeteners and colourants.
Ideally, pharmaceutical excipients are expected to be non-toxic, physically and 
chemically stable, commercially available, pleasant organoleptic properties and 
economically feasible [1].
This chapter will discuss the different chemical modifications of starch and give 
documented examples of starches that have been modified and used as excipients in 
pharmaceutical dosage forms.
2. Starch
Starch is one of the most abundant organic chemicals on earth and it is synthe-
sized in the amyloplasts of seeds, grain, roots and tubers of many plants where it 
serves as the chemical storage form of energy from the sun [2]. It is a carbohydrate 
consisting of a large number of glucose units joined by glycosidic bonds. It is the 
most common carbohydrate in the human diet and is contained in large amounts in 
such staple foods as potatoes, wheat, maize (corn), rice, and cassava [3]. Pure starch 
is a white, tasteless and odourless powder that is, insoluble in cold water or alcohol. 
It consists of two types of molecules: the linear helical amylose and the branched 
amylopectin. Depending on the plant, starch generally contains 20–25% amylose 
and 75–80% amylopectin by weight [4]. The amylose portion is a macromolecule 
that is, linear in nature, while the amylopectin is the highly branched portion of 
the starch. Glycogen, the glucose store of animals, is a more branched version of 
amylopectin.
Starch is the most commonly used excipient in the pharmaceutical industry and 
this wide application is premised on its availability, low cost, high caloric value, 
inherent excellent physicochemical properties and the ease of its modification 
to other derivatives. The versatility of starch in industrial applications is clearly 
defined by its physicochemical properties; therefore a thorough evaluation of the 
necessary parameter is important in elucidating its industrial use. The morphology 
and physicochemical characteristics of starch are typical of its biological origin; 
hence starch from each plant source will vary somewhat in appearance, composi-
tion and properties [2].
The preclusion of the application of starch in its native form in the pharmaceuti-
cal industry is based on certain setbacks that have necessitated the need to modify 
starches to achieve the objective of the formulation scientist in ensuring the produc-
tion of standard tablets, thereby circumventing the limitations inherent in the use 
of native starch as pharmaceutical ingredients. Such setbacks that have been linked 
to the unfavourable properties of native starch include poor solubility, poor flow 
properties and high hydrophilicity.
Starch has been extensively modified to stabilize the granules during processing. 
This involves restructuring the starch granules and dispersion of the amylopectin 
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polymers within the granules, thus ensuring that the reactive polymers are acces-
sible to the reactants. Consequently, the profile of starch (after modification) is 
enhanced as an excipient in the drug manufacturing industry. Starch can be modi-
fied through chemical degradation, physical alteration, enzymatic modifications or 
genetic transformation.
3. Degradation of starch
Starch degradation proceeds under basic conditions and the extent of degrada-
tion depends on the several factors such as the presence or absence of oxygen, 
concentration of the base used, duration of the reaction and the temperature at 
which it occurs. Matsunaga and Seib reported the liberation of the proteins and 
lipids present in wheat starch when exposed to 0.4%w/w dilute aqueous alkali solu-
tion at 25°C. It was documented that the process of degradation was slowed down 
by the presence of hydroxyl ions [5]. In the presence of oxygen, starch degradation 
is a slow process that has a direct relationship with the concentration of alkali. 
However, it is not all parts of starch that undergoes degradation when exposed to 
alkali conditions. Those parts that are alkali resistant to degradation are sensitive to 
the presence of acids, thus suggesting that starch has selective degradation, depend-
ing on the chemical used.
The reducing end of the macromolecular chain of starch has been suggested to 
be the point where starch degradation progresses from; hence, the reducing-termi-
nal glucose units, even in branched structures, are split off, indicating that, not only 
amylose but also amylopectin is alkali labile [6].
Starch can be degraded by pregelatinization. Gelatinization involves the disrup-
tion of the crystalline and granular structures of starch when heat and water are 
applied. The presence of excess water (not less than 90%w/w) causes the starch 
granules to swell due to preferential solubility of the amylose molecules in water. 
When heat is applied and the gelatinization temperature is exceeded, the crystal-
line region of the starch becomes irreversibly disoriented, eventually leading to 
lattice disruption. Alabi et al. pregelatinized millet, sorghum and cocoyam starches 
and the process resulted in better flowability and compressibility than the natural 
starches. Tramadol tablets prepared with freeze-dried pregelatinized starches gen-
erally exhibited higher crushing strength but lower friability than those prepared 
with the natural starches [7].
4. Chemical modification of starch in drug formulations
The biodegradable nature of starch, presence of certain functional groups and 
the granular structure (macroscopic) have contributed significantly to the chemi-
cal modifications that starch is susceptible to. Moreover, the presence and location 
of hydroxyl groups at C2, C3 and C6 increases this susceptibility to substitution 
reactions [8]. Figure 1 shows a representation of the different methods of chemical 
modifications of starch in the pharmaceutical industry.
Chemical modification of starch usually follows the pathway of substitution, 
degradation or cross-linking, and these methods are employed to optimize the 
structural and nutritional properties for targeted applications. Enhancement of 
the thermoplasticity of starch is achieved by chemical modification of starch, 
thus causing a disorientation of the hydrogen bonds between the hydroxyl groups 
of the native starch, and disruption of the crystalline nature. Subsequently, the 
starch is becomes more fluid and the temperature at which it melts become lowered. 
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Moreover, the reduction in the number of hydroxyl groups due to the chemi-
cal modification increases the hydrophobicity of the starch. The most common 
approaches to chemical modification of starches for pharmaceutical use include oxi-
dation, hydrolysis, esterification and etherification. However, several approaches 
that involve a combination of the aforementioned chemical modification methods 
are also applicable.
Starches can be chemically modified following different pathways:
i. Liquid pathway: here, the chemical modification is carried out in a water 
medium. The starch is formulated as a suspension (with water as the vehicle) 
and the chemical modification is carried out until the desired property of the 
starch is achieved.
ii. Semi-solid pathway: this involves the chemical modification of native 
starch in form of a paste or gel. The resultant modified starch is usually dried 
by lyophilisation.
iii. Solid pathway: dry native starch is modified using the liquid form of 
the derivatization chemical as the medium, usually at a high temperature 
(≥1000°C).
Generally, the biodegradable nature of starch due to its macroscopic 
granular structure and presence of several functional groups makes it easily 
susceptible to modification. The glucose residues of starch are responsible for 
its chemical reactivity, and as mentioned earlier, the presence of the hydroxyl 
on the amylose and amylopectin are prone to the oxidation, reduction and 
hydrogen bond formation that starch undergoes in the process of chemical 
modification. The occurrence of large-sized grains in the granular structure 
exposes starch to external factors, thereby enhancing modification. The pen-
etrating ability of the chemical involved in the modification process, into the 
starch granular surface or the interior also influences the chemical modification 
of starch.
Figure 1. 
Methods of chemical modification of starch.
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5. Starch modification by oxidation
Starch modification by oxidation, which is one of the most common modifica-
tion methods, involves oxidation of primary or secondary hydroxyl groups of the 
glucose units with formation of aldehyde or carboxyl groups. The oxidized starch 
has better water solubility and lower viscosity tendency in comparison to the native 
one [9]. The type of oxidant used, the botanical origin of starch, and the process 
conditions are all determinants of how effective the oxidation is. Moreover, the 
oxidation reaction may cause loosening of intermolecular bonds and/or partial 
depolymerization of the polymer chains [10]. It is worthy of mention that not all 
methods of oxidation are applicable for use in the pharmaceutical industry. Aerobic 
oxidation methods are not applicable for use in the pharmaceutical industry, simply 
due to the unique category of reactions that simply cannot be performed in batches 
as applicable in most starch oxidation techniques.
Oxidation with hydrogen peroxide appears very promising, especially because of 
the production of non-toxic residues such as water. However, a limitation of the use 
of hydrogen peroxide is its low reactivity towards most organic functional groups 
and the fact that in the presence of the compounds with electrophilic character it 
behaves as a nucleophile, not exhibiting oxidizing properties [11]. This limitation 
of hydrogen peroxide can be improved by the use of metal ions as catalysts, subse-
quently leading to heavy metal contamination of the modified starch.
Oxidation of starch with sodium hypochlorite involves the oxidation of the 
primary hydroxyl groups to either aldehyde or carboxyl groups. High concentration 
of the oxidant in an acidic medium has a direct relationship with the progression 
of oxidation as more of starch is oxidized in the aforementioned conditions. The 
modification of the hydroxyl group is affected by the protein content of the starting 
material considering the fact that any reaction on the starch is preceded by oxida-
tion of the proteins. The starch oxidized by sodium hypochlorite is characterized by 
higher resistance to amylase activity and better stability at higher temperature and 
is capable of complexing calcium ions while exhibiting the polyelectrolyte proper-
ties [8]. Chemical oxidation of starch can also be carried out using sodium peri-
odate. The bonds of the carbon atoms on the second and third positions are cleaved 
and dialdehyde groups are formed within the starch structure.
Garrido et al. successfully demonstrated the increase in the crystallinity, better 
water solubility and lower viscosity of cassava starch when modified by oxidation 
using sodium hypochlorite [12].
6. Starch modification by esterification
The hydrophobicity of starch is improved by the process of esterification, sub-
sequently leading to improved thermoplasticity of the starch. Starch forms esters 
with reagents (organic and inorganic acids, and their derivatives such as chlorides, 
oxychlorides and acid anhydrides) due to the presence of the hydroxyl groups on 
each glucose residue, been converted to hydrophobic ester groups.
6.1 Esterification by acetylation
This is carried out with the aid of acetic acid or acetic anhydride. The esterifica-
tion can be carried out in the presence of acetic acid as an activator or with acetic 
anhydride in the presence of sodium hydroxide as the activator [13]. A high degree 
of substitution was obtained when potassium carbonate was applied as the activa-
tor in the reaction of starch with acetic anhydride [14]. Starch acetates have been 
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used extensively in the pharmaceutical industry as binders. In 2011, Singh and 
Nath demonstrated the potential of acetylated moth bean starch as a carrier for 
controlled drug delivery of lamivudine tablets [15]. On a micro scale, starches can 
be acetylated without the presence of a catalyst. The process involves heating the 
native starch with acetic acid at a temperature between 179 and 181°C for a period 
of 2–4 min, resulting in a homogenous mixture. Tuovinen et al. documented the 
potential of natural sensitive starch acetate as an excipient in the retinal delivery of 
calcein; the in-vivo studies revealed that starch acetate nanoparticles, when com-
pared with native starch, were taken up faster by reticuloendothelial cells without 
significant toxicity [16]. Akin-Ajani et al. also demonstrated the increase in crush-
ing strength and disintegration time but lower friability of acid modified white 
fonio (Digitaria exilis) and sweet potatoe (Ipomea batatas) starches when incorpo-
rated as exo-disintegrants in paracetamol tablet formulations [17].
6.2 Esterification by phosphorylation
Phosphorylation of starch enhances the rheological and pasting properties of 
starch, which improves the flowability of starch when used in tablet formulation 
as documented by Adetunji and Kolawole [18]. This is as a result of addition of 
phosphate groups to the C6 position of the glucose residue [19].
Starch phosphate esters containing magnesium, calcium, or aluminum ions are 
used extensively as disintegrants in the pharmaceutical industry. Monostarch phos-
phate is obtained by treating starch with potassium or sodium phosphates, while 
distarch phosphates can be obtained by treating starch with phosphorus oxychlo-
ride or sodium trimetaphosphate. The degree of cross-linking of phosphorylated 
starch determines the swelling ability of the modified starch. At a low degree of 
cross-linking, starch has high swelling ability but with increasing degree of cross-
linking; swelling ability in water decreases, until complete loss of this ability [20].
Zuo et al. documented the use of maleic anhydride in the esterification of corn 
starch. The esterification led to roughness on the surface of the starch particle with a 
subsequent increase in particles size. Crystal lattice destruction of the starch during the 
maleic anhydride esterification also led to improved thermoplasticity and reduction in 
gelatinization temperature [21]. Phosphorylated starch yielded a better result than native 
starch when Prosanthi and Rama incorporated it a disintegrant in Ziprasidone tablet 
formulations [22], while starches from various botanical sources with different amylose 
contents (way corn, common corn, Hylon V, Hylon VII and potatoe) were phosphory-
lated at pH 9.0 and 11.0 using reactive extrusion method prior to their use in the for-
mulation of sustained release metoprolol tartrate tablets; these phosphorylated starches 
produced stronger hydrogels than the corresponding native starch [23]. Chowdary et al. 
used phosphorylated potatoe starch prepared by the reaction of the native starch with 
di-sodium hydrogen orthophosphate anhydrous at elevated temperatures as a carrier in 
solid dispersions for enhancing the dissolution rate of aceclofenac; better results were 
achieved from the formulations containing the phosphorylated starches [24].
7. Starch modification by etherification
Etherification of starch is a derivatization technique that involves the use of 
various alkylation agents such as dimethyl sulphate, diethyl sulphate, alkylene 
oxides (epoxides) and alkyl halides. The use of diethyl (or dimethyl) sulphates in 
starch etherification was documented to have taken place in dimethyl sulfoxide with 
the addition of aqueous sodium chloride [25]. Starch ethers with branched chains 
are usually produced through reactions with alkyl halides.
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The use of epoxides in starch etherification can proceed in the absence of 
sodium hydroxide. According to Cui, the high reactivity of the asymmetrical epox-
ide group is due to the highly strained three-membered ring with bond angles of 60° 
[25]. Etherification of macrogranular starch (containing ≤10%w/w moisture) by 
pressurized hot air can also be carried out using ethylene oxide [26].
Starch etherification involving the introduction of ammonium, amino or imino 
group yields important industrial derivatives. The use of different amino-alkyl 
agents, such as 2-diethylaminoethyl chloride, 2,3-(epoxypropyl), trimethylam-
monuim chloride, (4-chlorobutene-2)-trimethylammonium chloride, etc., in 
etherification is a major way of producing cationic starches with enhanced gelatini-
zation behavior, pasting properties and solubility [6].
Carboxymethylated starches are derivatives of etherification of starch that are 
formed when hydrogen atoms are replaced by carboxymethyl functional groups. 
Carboxymethylated starches have been documented to show low gelatinization 
temperature and swelling properties and, solubility in cold water than most 
interesting native starches [27]. Synthesis of carboxymethyled starch involves 
initial activation of the native starch with aqueous sodium hydroxide in an organic 
slurry, followed by the reaction with monochloroacetic acid or its sodium salt. The 
tablet film-coating potential of carboxymethylated mungbean starch was reported 
by Kittipongpatana et al. as due to the formation of clear, thin film with greater 
flexibility and strength than that of the native starch [28]. Drug release was better 
sustained when high amylose sodium carboxymethylated starch matrices were used 
in the formulation of oral acetaminophen tablets [29].
8. Conclusion
The modification of starch using different approaches such as oxidation, 
esterification and esterification is well documented in literature. While small scale 
researches have substantiated the usefulness of modified starches as excellent excipi-
ents in the manufacture of different dosage forms due to enhancement of characters 
such as flow properties of starch, favorable particle size, robust crystallinity etc., it 
is pertinent to develop more methods of chemically modifying starch that can be 
scaled-up in the pharmaceutical industry to increase the options that drug formula-
tion scientists can exploit when choosing excipients for drug dosage form designs.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
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